Oxytocin as a treatment for toddlers with autism

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Autism is characterised by deficits in social behaviour and communication, and is a cause of major lifelong disability. A novel intervention, oxytocin nasal spray, enhances social cognition and behaviour in humans, including in those with autism spectrum disorders. This project will determine whether oxytocin, taken twice daily over 8 weeks, improves social communication and interaction skills in toddlers with autism. This project represents a crucial step in developing an early intervention treatment for autism.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2018

Funding Scheme: Project Grants

Funding Amount: $494,012.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Health, Clinical and Counselling Psychology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

autism | child health | developmental disorders | intervention study | oxytocin